Original Research

Published on 07 Nov 2022

NK cells with decreased expression of multiple activating receptors is a dominant phenotype in pediatric patients with acute lymphoblastic leukemia

in Hematologic Malignancies

Lucero Valenzuela-Vázquez
Juan Carlos Nuñez-Enriquez
Jacqueline Sánchez-Herrera
Aurora Medina-Sanson
María Luisa Pérez-Saldivar
Elva Jiménez-Hernández
Jorge Alfonso Martiín-Trejo
María de Los Ángeles Del Campo-Martínez
Janet Flores-Lujano
Raquel Amador-Sánchez

Frontiers in Oncology

doi 10.3389/fonc.2022.1023510

2,760 views
7 citations

Review

Published on 03 Nov 2022

The 8p11 myeloproliferative syndrome: Genotypic and phenotypic classification and targeted therapy

in Hematologic Malignancies

Taotao Li
Gaoling Zhang
Xiaoling Zhang
Hai Lin
Qiuju Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.1015792

4,830 views
5 citations

Review

Published on 02 Nov 2022

Acquired and hereditary bone marrow failure: A mitochondrial perspective

in Hematologic Malignancies

Waseem Nasr
Marie-Dominique Filippi

Frontiers in Oncology

doi 10.3389/fonc.2022.1048746

3,934 views
7 citations

Original Research

Published on 31 Oct 2022

Activity and rational combinations of a novel, engineered chimeric, TRAIL-based ligand in diffuse large B-cell lymphoma

in Hematologic Malignancies

Karolina Piechna
Aleksandra Żołyniak
Ewa Jabłońska
Monika Noyszewska-Kania
Maciej Szydłowski
Bartłomiej Żerek
Maria Kulecka
Izabela Rumieńczyk
Michał Mikula
Przemysław Juszczyński

Frontiers in Oncology

doi 10.3389/fonc.2022.1048741

2,737 views
3 citations

Case Report

Published on 31 Oct 2022

Acute necrotizing encephalopathy associated with lymphoma-associated hemophagocytic lymphohistiocytosis: A case report and literature review

in Hematologic Malignancies

Wenqiang Sun
Changchang Fu
Xueping Zhu

Frontiers in Oncology

doi 10.3389/fonc.2022.986957

1,511 views
2 citations

Editorial

Published on 31 Oct 2022

Editorial: Novel mechanisms for the treatment of AML before and after transplant

in Hematologic Malignancies

Margaret T. Kasner

Frontiers in Oncology

doi 10.3389/fonc.2022.1063307

923 views

Original Research

Published on 31 Oct 2022

Mass cytometry analysis reveals attrition of naïve and anergized self-reactive non-malignant B cells in chronic lymphocytic leukemia patients

in Hematologic Malignancies

Thibault Andrieu
Paul Mondière
Pierre-Emmanuel Jouve
Sébastien Dussurgey
Victor Malassigné
Hugo Servanton
Lucille Baseggio
Frédéric Davi
Anne-Sophie Michallet
Thierry Defrance

Frontiers in Oncology

doi 10.3389/fonc.2022.1020740

2,030 views
2 citations

Review

Published on 28 Oct 2022

Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemia

in Hematologic Malignancies

Alexander J. Ambinder
Amy E. DeZern

Frontiers in Oncology

doi 10.3389/fonc.2022.1033534

5,562 views
5 citations

Editorial

Published on 27 Oct 2022

Editorial: Characteristics and behaviors of hematopoietic stem cells and leukemia stem cells in hematologic malignancies

in Hematologic Malignancies

Haojian Zhang
Pengxu Qian

Frontiers in Oncology

doi 10.3389/fonc.2022.1037202

1,026 views

Systematic Review

Published on 27 Oct 2022

The prognostic value of Epstein−Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis

in Hematologic Malignancies

Jianyu Hu
Xue Zhang
Huan Tao
Yongqian Jia

Frontiers in Oncology

doi 10.3389/fonc.2022.1034398

2,876 views
5 citations

Review

Published on 27 Oct 2022

Hemophagocytic lymphohistiocytosis as an etiology of bone marrow failure

in Hematologic Malignancies

Jonathan Paolino
Nancy Berliner
Barbara Degar

Frontiers in Oncology

doi 10.3389/fonc.2022.1016318

8,439 views
6 citations

Review

Published on 27 Oct 2022

Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance

in Hematologic Malignancies

Mateo Mejia Saldarriaga
Walaa Darwiche
David Jayabalan
Jorge Monge
Cara Rosenbaum
Roger N. Pearse
Ruben Niesvizky
Mark Bustoros

Frontiers in Oncology

doi 10.3389/fonc.2022.1020011

4,180 views
7 citations

Review

Published on 27 Oct 2022

The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice

in Hematologic Malignancies

Matias Mendeville
Margaretha G. M. Roemer
G. Tjitske Los-de Vries
Martine E. D. Chamuleau
Daphne de Jong
Bauke Ylstra

Frontiers in Oncology

doi 10.3389/fonc.2022.970063

3,364 views
2 citations

Review

Published on 26 Oct 2022

High-cutoff hemodialysis in multiple myeloma patients with acute kidney injury

in Hematologic Malignancies

Yan Xing
Jipeng Yan
Zixian Yu
Jin Zhao
Yuwei Wang
Xiayin Li
Yunlong Qin
Shiren Sun

Frontiers in Oncology

doi 10.3389/fonc.2022.1024133

6,831 views
7 citations

Review

Published on 25 Oct 2022

PAX5 alterations in B-cell acute lymphoblastic leukemia

in Hematologic Malignancies

Zhilian Jia
Zhaohui Gu

Frontiers in Oncology

doi 10.3389/fonc.2022.1023606

10,634 views
14 citations

Case Report

Published on 24 Oct 2022

CD19 chimeric antigen receptor T-cell therapy following autologous stem cell transplantation against relapsed or refractory Burkitt lymphoma/leukemia: A case report and literature review

in Hematologic Malignancies

Mingyu Ye
Lei Gao
Tao Wang
Jiechen Yu
Jiaping Gui
Jianmin Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.932254

2,043 views
2 citations

Navigation group

Articles

NK cells with decreased expression of multiple activating receptors is a dominant phenotype in pediatric patients with acute lymphoblastic leukemia

The 8p11 myeloproliferative syndrome: Genotypic and phenotypic classification and targeted therapy

Acquired and hereditary bone marrow failure: A mitochondrial perspective

Activity and rational combinations of a novel, engineered chimeric, TRAIL-based ligand in diffuse large B-cell lymphoma

Acute necrotizing encephalopathy associated with lymphoma-associated hemophagocytic lymphohistiocytosis: A case report and literature review

Editorial: Novel mechanisms for the treatment of AML before and after transplant

Mass cytometry analysis reveals attrition of naïve and anergized self-reactive non-malignant B cells in chronic lymphocytic leukemia patients

Navigating the contested borders between myelodysplastic syndrome and acute myeloid leukemia

Editorial: Characteristics and behaviors of hematopoietic stem cells and leukemia stem cells in hematologic malignancies

The prognostic value of Epstein−Barr virus infection in Hodgkin lymphoma: A systematic review and meta-analysis

Hemophagocytic lymphohistiocytosis as an etiology of bone marrow failure

Advances in the molecular characterization of multiple myeloma and mechanism of therapeutic resistance

The path towards consensus genome classification of diffuse large B-cell lymphoma for use in clinical practice

High-cutoff hemodialysis in multiple myeloma patients with acute kidney injury

PAX5 alterations in B-cell acute lymphoblastic leukemia

CD19 chimeric antigen receptor T-cell therapy following autologous stem cell transplantation against relapsed or refractory Burkitt lymphoma/leukemia: A case report and literature review